There is a world beyond protein mutations: The role of non-coding RNAs in melanomagenesis

Experimental Dermatology

Volumn 22, Issue 5, 2013, Pages 303-306

  Swoboda, Rolf K ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Alternative splicing; Epigenetic modifications; Melanoma; MicroRNA; Non coding RNA

Indexed keywords

MICRORNA;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CUTANEOUS MELANOMA; GENE EXPRESSION; GENE MUTATION; HISTONE MODIFICATION; HUMAN; NOTE;

ALTERNATIVE SPLICING; EPIGENESIS, GENETIC; HUMANS; MELANOMA; MICRORNAS; MUTATION; RNA, UNTRANSLATED; SKIN NEOPLASMS;

EID: 84876846076     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12117     Document Type: Note

References (98)

1. Jemal A, Siegel R, Ward E et al. CA Cancer J Clin 2006: 56: 106-130.
2. Villanueva J, Herlyn M. Curr Oncol Rep 2008: 10: 439-446.
3. Pietras K, Ostman A. Exp Cell Res 2010: 316: 1324-1331.
4. Hanahan D, Coussens L M. Cancer Cell 2012: 21: 309-322.
5. Davies H, Bignell G R, Cox C et al. Nature 2002: 417: 949-954.
6. Lee J H, Choi J W, Kim Y S. Br J Dermatol 2011: 164: 776-784.
7. Goldstein A M, Chan M, Harland M et al. Cancer Res 2006: 66: 9818-9828.
8. Walia V, Mu E W, Lin J C et al. Pigment Cell Melanoma Res 2012: 25: 155-170.
9. Wong C W, Fan Y S, Chan T L et al. J Clin Pathol 2005: 58: 640-644.
10. Harbour J W, Onken M D, Roberson E D et al. Science 2010: 330: 1410-1413.
11. Van Raamsdonk C D, Griewank K G, Crosby M B et al. N Engl J Med 2010: 363: 2191-2199.
12. Kumar R, Angelini S, Snellman E et al. J Invest Dermatol 2004: 122: 342-348.
13. Lin K, Baritaki S, Militello L et al. Genes Cancer 2010: 1: 409-420.
14. Knudson A G. J Cancer Res Clin Oncol 1996: 122: 135-140.
15. Tomlinson I P, Roylance R, Houlston R S. J Med Genet 2001: 38: 81-85.
16. Prickett T D, Agrawal N S, Wei X et al. Nat Genet 2009: 41: 1127-1132.
17. Wei X, Walia V, Lin J C et al. Nat Genet 2011: 43: 442-446.
18. Pleasance E D, Cheetham R K, Stephens P J et al. Nature 2010: 463: 191-196.
19. Berger M F, Hodis E, Heffernan T P et al. Nature 2012: 485: 502-506.
20. Berger M F, Levin J Z, Vijayendran K et al. Genome Res 2010: 20: 413-427.
21. Baitei E Y, Zou M, Al-Mohanna F et al. J Pathol 2009: 217: 707-715.
22. Chapman P B, Hauschild A, Robert C et al. N Engl J Med 2011: 364: 2507-2516.
23. Poulikakos P I, Persaud Y, Janakiraman M et al. Nature 2011: 480: 387-390.
24. Kapranov P, Willingham A T, Gingeras T R. Nat Rev Genet 2007: 8: 413-423.
25. Carninci P, Kasukawa T, Katayama S et al. Science 2005: 309: 1559-1563.
26. Djebali S, Davis C A, Merkel A et al. Nature 2012: 489: 101-108.
27. Lee S K, Calin G A. Discov Med 2011: 11: 245-254.
28. Guo H, Ingolia N T, Weissman J S et al. Nature 2010: 466: 835-840.
29. Iorio M V, Croce C M. EMBO Mol Med 2012: 4: 143-159.
30. Calin G A, Croce C M. Cancer Res 2006: 66: 7390-7394.
31. Lujambio A, Lowe S W. Nature 2012: 482: 347-355.
32. Davis-Dusenbery B N, Hata A. Genes Cancer 2010: 1: 1100-1114.
33. Melo S A, Esteller M. FEBS Lett 2011: 585: 2087-2099.
34. Stark M S, Tyagi S, Nancarrow D J et al. PLoS ONE 2010: 5: e9685.
35. Glud M, Gniadecki R. J Eur Acad Dermatol Venereol 2013: 27: 142-150.
36. Philippidou D, Schmitt M, Moser D et al. Cancer Res 2010: 70: 4163-4173.
37. Mueller D W, Bosserhoff A K. Pigment Cell Melanoma Res 2010: 23: 620-626.
38. Streicher K L, Zhu W, Lehmann K P et al. Oncogene 2012: 31: 1558-1570.
39. Ma L, Weinberg R A. Trends Genet 2008: 24: 448-456.
40. Mazar J, DeYoung K, Khaitan D et al. PLoS ONE 2010: 5: e13779.
41. Chan E, Patel R, Nallur S et al. Cell Cycle 2011: 10: 1845-1852.
42. Segura M F, Belitskaya-Levy I, Rose A E et al. Clin Cancer Res 2010: 16: 1577-1586.
43. Rossi J J. EMBO J 2011: 30: 4340-4341.
44. Hansen T B, Wiklund E D, Bramsen J B. et al. EMBO J 2011: 30: 4414-4422.
45. Mazar J, DeBlasio D, Govindarajan S S et al. FEBS Lett 2011: 585: 2467-2476.
46. Lipovich L, Johnson R, Lin C Y. Biochim Biophys Acta 2010: 1799: 597-615.
47. Brown C J, Ballabio A, Rupert J L et al. Nature 1991: 349: 38-44.
48. Wang X Q, Crutchley J L, Dostie J. Curr Genomics 2011: 12: 307-321.
49. Moran V A, Perera R J, Khalil A M. Nucleic Acids Res 2012: 40: 6391-6400.
50. Guttman M, Donaghey J, Carey B W et al. Nature 2011: 477: 295-300.
51. Mercer T R, Dinger M E, Mattick J S. Nat Rev Genet 2009: 10: 155-159.
52. Orom U A, Derrien T, Beringer M et al. Cell 2010: 143: 46-58.
53. Yin Q F, Yang L, Zhang Y et al. Mol Cell 2012: 48: 219-230.
54. Gibb E A, Vucic E A, Enfield K S et al. PLoS ONE 2011: 6: e25915.
55. Tsai M C, Spitale R C, Chang H Y. Cancer Res 2011: 71: 3-7.
56. Spizzo R, Almeida M I, Colombatti A et al. Oncogene 2012: 31: 4577-4587.
57. Khaitan D, Dinger M E, Mazar J et al. Cancer Res 2011: 71: 3852-3862.
58. Flockhart R J, Webster D E, Qu K et al. Genome Res 2012: 22: 1006-1014.
59. Cabili M N, Trapnell C, Goff L et al. Genes Dev 2011: 25: 1915-1927.
60. Gupta R A, Shah N, Wang K C et al. Nature 2010: 464: 1071-1076.
61. Baylin S B, Jones P A. Nat Rev Cancer 2011: 11: 726-734.
62. Schinke C, Mo Y, Yu Y et al. Melanoma Res 2010: 20: 253-265.
63. Sigalotti L, Covre A, Fratta E et al. J Transl Med 2010: 8: 56.
64. Johnstone S E, Baylin S B. Nat Rev Genet 2010: 11: 806-812.
65. O'Hagan H M, Wang W, Sen S et al. Cancer Cell 2011: 20: 606-619.
66. Maegawa S, Hinkal G, Kim H S et al. Genome Res 2010: 20: 332-340.
67. Issa J P, Garber J E. Cancer Prev Res (Phila) 2011: 4: 6-8.
68. Su W Y, Xiong H, Fang J Y. Biochem Biophys Res Commun 2010: 396: 177-181.
69. Knee R S, Pitcher S E, Murphy P R. Biochem Biophys Res Commun 1994: 205: 577-583.
70. Chen J, Sun M, Kent W J et al. Nucleic Acids Res 2004: 32: 4812-4820.
71. Katayama S, Tomaru Y, Kasukawa T et al. Science 2005: 309: 1564-1566.
72. Vanhee-Brossollet C, Vaquero C. Gene 1998: 211: 1-9.
73. Luco R F, Misteli T. Curr Opin Genet Dev 2011: 21: 366-372.
74. Morrissy A S, Griffith M, Marra M A. Genome Res 2011: 21: 1203-1212.
75. Hu A, Fu X D. Nat Struct Mol Biol 2007: 14: 174-175.
76. Ghigna C, Valacca C, Biamonti G. Curr Genomics 2008: 9: 556-570.
77. Wang Z, Gerstein M, Snyder M. Nat Rev Genet 2009: 10: 57-63.
78. Pan Q, Shai O, Lee L J et al. Nat Genet 2008: 40: 1413-1415.
79. Watahiki A, Waki K, Hayatsu N et al. Nat Methods 2004: 1: 233-239.
80. Li C, Kato M, Shiue L et al. Cancer Res 2006: 66: 1990-1999.
81. Primot A, Mogha A, Corre S et al. Pigment Cell Melanoma Res 2010: 23: 93-102.
82. Ge K, DuHadaway J, Du W et al. Proc Natl Acad Sci USA 1999: 96: 9689-9694.
83. Bartel F, Harris L C, Wurl P et al. Mol Cancer Res 2004: 2: 29-35.
84. Brinkman B M. Clin Biochem 2004: 37: 584-594.
85. Van Emburgh B O, Robertson K D. Nucleic Acids Res 2011: 39: 4984-5002.
86. Luco R F, Allo M, Schor I E et al. Cell 2011: 144: 16-26.
87. Durand C, Roeth R, Dweep H et al. PLoS ONE 2011: 6: e18115.
88. Makeyev E V, Zhang J, Carrasco M A et al. Mol Cell 2007: 27: 435-448.
89. Song M S, Salmena L, Pandolfi P P. Nat Rev Mol Cell Biol 2012: 13: 283-296.
90. Alimonti A, Carracedo A, Clohessy J G et al. Nat Genet 2010: 42: 454-458.
91. Carracedo A, Alimonti A, Pandolfi P P. Cancer Res 2011: 71: 629-633.
92. Tay Y, Kats L, Salmena L et al. Cell 2011: 147: 344-357.
93. Salmena L, Poliseno L, Tay Y et al. Cell 2011: 146: 353-358.
94. Sumazin P, Yang X, Chiu H S et al. Cell 2011: 147: 370-381.
95. Kole R, Krainer A R, Altman S. Nat Rev Drug Discov 2012: 11: 125-140.
96. Ingolia N T, Lareau L F, Weissman J S. Cell 2011: 147: 789-802.
97. Touriol C, Bornes S, Bonnal S et al. Biol Cell 2003: 95: 169-178.
98. Gallo A, Galardi S. RNA Biol 2008: 5: 135-139.